一个由罗菲科克西布衍生出的疗效探针及其与PD-1抑制剂的组合,用于高效的癌症治疗
Xinli Wang1, Xia Wang2, Xuejing Su2,3
1Department of Medical Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, People's Republic of China.
Archiv der Pharmazie
|December 12, 2025
概括
一种新的循环氧化酶-2 (COX-2) 向探针增强了瘤可视化,并实现了显著的瘤回归. 将这种探针与编程细胞死亡蛋白1 (PD-1) 抑制剂相结合,导致95%的瘤回归.
科学领域:
- 在瘤学瘤学.
- 分子成像学分子成像学
- 药物开发 药物开发
背景情况:
- 精确瘤学在开发瘤特异向和有效性的光学探针方面面临着挑战.
- 循环氧化原酶-2 (COX-2) 是癌症治疗中验证的标.
研究的目的:
- 开发一种新的COX-2光探针,用于增强瘤可视化和治疗干预.
- 为了评估开发的探针的单疗法和组合疗法疗效.
主要方法:
- 一个由罗菲科西布衍生的COX-2向探针 (化合物2) 的合成.
- 在体外结合COX-2时对化合物2的光增强的评估.
- 在体内对复合物2单一治疗和与PD-1抑制剂的联合治疗的评估.
主要成果:
- 化合物2在最小的背景条件下在COX-2结合时显示出六倍的光增强.
- 化合物2单一治疗导致53%的瘤回归.
- 与PD-1抑制剂的联合治疗通过阻断COX-2/PGE2和PD-1/PD-L1通路实现了95%的瘤回归.
结论:
- 开发的COX-2准探头提供了改进的瘤可视化和治疗潜力.
- 同时阻断COX-2/PGE2和PD-1/PD-L1轴可显著提高抗瘤功效.
- 这种治疗术的方法为推进癌症诊断和治疗提供了一个有希望的策略.
关键词:
罗菲科西布 (Rofekoxib) 是一种药物.癌症 癌症 癌症 癌症 癌症循环氧基因酶-2 (COX-2) 基因酶-2 (COX-2) 基因酶-2 (COX-2) 基因酶-2) 基因酶-2 (COX-2) 基因酶-2 (COX-2) 基因酶-2 (COX-2) 基因酶-2) 基因酶-2 (COX-2) 基因酶-2 (COX-2) 基因酶-2 (COX-2) 基因酶-2 (COX-2) 基因酶-2) 基因酶-2 (COX-2) 基因酶-2 (COX-2) 基因酶-2 (COX-2) 基因酶-2 (COX-2) 基因酶-2光是一种光.编程细胞死亡蛋白1 (PD-1) 编程细胞死亡蛋白1太空探测探测器探测器相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K


